Takeda Pharmaceutical Company Limited (TYO:4502)
5,050.00
+124.00 (2.52%)
Jun 8, 2026, 3:30 PM JST
Takeda Pharmaceutical Company Employees
Takeda Pharmaceutical Company had 47,455 employees as of March 31, 2025. The number of employees decreased by 1,826 or -3.71% compared to the previous year.
Employees
47,455
Change (1Y)
-1,826
Growth (1Y)
-3.71%
Revenue / Employee
94.95M JPY
Profits / Employee
4.04M JPY
Market Cap
7.98T
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 47,455 | -1,826 | -3.71% |
| Mar 31, 2024 | 49,281 | 186 | 0.38% |
| Mar 31, 2023 | 49,095 | 1,748 | 3.69% |
| Mar 31, 2022 | 47,347 | 248 | 0.53% |
| Mar 31, 2021 | 47,099 | -396 | -0.83% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Eisai | 10,917 |
| Toho Holdings | 7,609 |
| Shionogi & | 4,955 |
| Towa Pharmaceutical | 4,788 |
| Tsumura & Co. | 4,272 |
| Sumitomo Pharma | 3,832 |
| Sawai Group Holdings | 3,310 |
| Nippon Shinyaku | 2,243 |
Takeda Pharmaceutical Company News
- 5 days ago - Takeda Pharmaceutical Company Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 6 days ago - Takeda Pharmaceutical Co Ltd (TAK) Shares Fall 4.8% -- GF Value Says Still Overvalued - GuruFocus
- 16 days ago - Takeda Pharmaceutical is Now Oversold (TAK) - Nasdaq
- 20 days ago - Takeda Ordered To Pay $884.9 Mln In AMITIZA Antitrust Case; To Revise FY25 Results - Nasdaq
- 20 days ago - Takeda Pharmaceutical (TAK) Found Guilty in Generic Drug Delay Conspiracy - GuruFocus
- 20 days ago - Attorneys at Hagens Berman Announce $474M Win in Amitiza Jury Trial Against Takeda - Business Wire
- 20 days ago - Jury finds Takeda caused about $885M in damages over generic delay, Reuters says - TheFly
- 20 days ago - Takeda engaged in antitrust scheme to delay generic constipation drug, US jury finds - Reuters